Home / National / First-ever phase-three clinical trial for dengue vaccine initiated in India

First-ever phase-three clinical trial for dengue vaccine initiated in India

The indigenous vaccine, DengiAll, has been developed by Panacea Biotec; the phase 3 clinical trial is being conducted by ICMR and the pharma company on over 10,000 participants across 18 States
Share this news

About @click197 - B TELEGRAM BAM 423 751 RUB TINKOFF

Check Also

इंडिगो संकटः डीजीसीए ने 4 उड़ान संचालन निरीक्षकों को पदमुक्त किया

नई दिल्ली। देश की सबसे बड़ी विमानन कंपनी इंडिगो के संकट के 11 वें दिन …